- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03707704
Quality Control of a Strengthening Protocol in Subjects With Spinal Cord Injury (MKraft_Erstr)
Quality Control of an In-hospital Strengthening Protocol in Spinal Cord Injured Subjects During Initial Rehabilitation - a Prospective Observational Study
The aim of the master's thesis is to evaluate the clinic-internal strengthening concept of the Swiss Paraplegic Centre (SPZ). The SPZ is a rehabilitation clinic for spinal cord injured people. The strengthening concept has been routinely used since 2015.
By default, the patients complete - depending on which training phase they are in - three to four strength training sessions per week. As part of the master's thesis, the development of maximum strength of patients with spinal cord injury (SCI) in primary rehabilitation will be studied. It is explicitly taken care of that the patients comply with the training requirements. Furthermore, factors which prevent a consistent buildup of strength - such as medical complications (pressure sores, pneumonia, urinary tract infections) - are systematically recorded.
The findings should provide information on the effect and qualitative transfer of the existing strength concept in everyday clinical practice. The strength training performed is accompanied by the master student and documented in a standardized manner.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Lucerne
-
Nottwil, Lucerne, Switzerland, 6207
- Swiss Paraplegic Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients in initial rehabilitation
- SCI Level C1-C5 (ASIA Score C-D)
- SCI Lever C6-L5 (ASIA Score A-D)
- Traumatic and non-traumatic SCI
- Disease-related paraplegia, high-grade stenoses and central cord Syndromes
- Age >= 18 years
- The maximum force is tested on three predefined training devices, two devices for the upper and a device for the lower extremity. The participants will only be included in the study if they are capable of succeeding in at least both exercises for the upper extremity
Exclusion criteria:
- Polyneuropathic diseases such as Critical Illness and Guillain Barré Syndrome
- Degenerative diseases such as multiple sclerosis and amyotrophic lateral sclerosis etc.
- Cognitive impairments
- Compliance of less than 2/3 of the training sessions
- ≥ 14 days without training
- more than 6 weeks between assessments
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
SCI patients in primary rehabilitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
One-repetition-maximum as parameter for the maximum force [kg]
Time Frame: Change from 0 weeks to 5 weeks and from 5 weeks to 10 weeks
|
Calculated one-repetition-maximum based on the Brzycki equation formula
|
Change from 0 weeks to 5 weeks and from 5 weeks to 10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of completed training sessions (training compliance)
Time Frame: Change from 0 weeks to 5 weeks and from 5 weeks to 10 weeks
|
Number of completed training sessions per participant
|
Change from 0 weeks to 5 weeks and from 5 weeks to 10 weeks
|
Causes of study exclusion
Time Frame: From 0 weeks to 10 weeks
|
Systematic documentation of exclusion causes during the participation in the study
|
From 0 weeks to 10 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-16
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injury, Acute
-
Jill M. Wecht, Ed.D.Icahn School of Medicine at Mount SinaiRecruitingBlood Pressure | Spinal Cord Injuries | SCI - Spinal Cord Injury | Blood Pressure Disorders | Traumatic Spinal Cord Injury | Acute Spinal Cord Injury | Neuromodulation | Spinal Cord StimulationUnited States
-
University of British ColumbiaRecruitingSpinal Cord Injuries | Acute Spinal Cord Injury | Acute Spinal Paralysis | Trauma, Spinal CordCanada
-
Kringle Pharma, Inc.Recruiting
-
AlaMab Therapeutics (Shanghai) Inc.RecruitingAcute Spinal Cord InjuryChina
-
University of KentuckyRecruiting
-
University of British ColumbiaUnited States Department of DefenseRecruitingSpinal Cord Injuries | Acute Spinal Cord InjuryCanada
-
Pharmazz, Inc.Recruiting
-
Ohio State UniversityTerminated
-
Chinese Academy of SciencesThe First Affiliated Hospital of Soochow University; General Hospital of Ningxia... and other collaboratorsUnknownAcute Spinal Cord InjuryChina
-
University of CalgaryHotchkiss Brain Institute, University of Calgary; AANS/CNS Section on Disorders...TerminatedAcute Spinal Cord InjuryUnited States, Canada